LINC02174

Across TCGA pan-cancer cohorts, LINC02174 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC02174 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02174 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02174 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

STAD, CESC, and SKCM are the cancer types where LINC02174 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.424	0.675	<.001	75	view →
CESC	OS	Tertile	All	0.227	0.798	.002	54	view →
SKCM	DFS	Tertile	All	0.248	0.733	<.001	33	view →
GBM	OS	Tertile	All	0.097	0.419	<.001	27	view →
PRAD	DFS	Tertile	All	0.621	0.886	.039	18	view →
THYM	DFS	Tertile	III,IV	0.205	0.774	.007	9	view →
LUAD	DFS	Tertile	III,IV	0.036	0.673	<.001	9	view →
LUSC	DFS	Tertile	III,IV	1.000	0.270	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC02174–STAD (DFS)

Open the STAD breakdown →